Drugs and Devices

FDA approves new device for asthma

On April 27, the U.S. Food and Drug Administration approved the first medical device that uses radiofrequency energy to treat severe and persistent asthma in adults. The Alair Bronchial Thermoplasty System is intended for patients whose severe and persistent asthma is not well-controlled with medications. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm209909.htm


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares